Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: Identification of patients at risk

Transfusion

Volumn 50, Issue 3, 2010, Pages 649-655

  Dahl, Daphne ^b   Hahn, Andreas ^b   Koenecke, Christian ^b   Heuft, Hans Gert ^b   Dammann, Elke ^b   Stadler, Michael ^b   Buchholz, Stefanie ^b   Krauter, Jürgen ^b   Eder, Matthias ^b   Sykora, Karl Walter ^b   Klein, Christoph ^b   Ganser, Arnold ^b   Sauer, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGE; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; CHIMERA; DELAYED RED BLOOD CELL CHIMERISM; ERYTHROCYTE TRANSFUSION; FEMALE; HIGH RISK PATIENT; HLA MATCHING; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PROTECTION; PURE RED CELL ANEMIA; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; RISK FACTOR;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RED-CELL APLASIA, PURE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 77649225949     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02461.x     Document Type: Article

References (24)

1. O'Brien TA, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK, Baker KS. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004 127 : 67 75.
2. Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007 39 : 555 61.
3. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995 15 : 825-828.
4. Canals C, Muniz-Diaz E, Martinez C, Martino R, Moreno I, Ramos A, Arilla M, Boto N, Pastoret C, Remacha A, Sierra J, Madoz P. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 2004 44 : 1603 11.
5. Helbig G, Stella-Holowiecka B, Wojnar J, Krawczyk M, Krzemien S, Wojciechowska-Sadus M, Markiewicz M, Wylezol I, Kopera M, Holowiecki J. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. Ann Hematol 2007 86 : 677 83.
6. Benjamin RJ, Connors JM, McGurk S, Churchill WH, Antin JH. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 1998 4 : 151 6.
7. Marmont AM, Damasio EE, Bacigalupo A, Giordano D, Rossi E, Reali G, Gay A, Dagna-Bricarelli F, Brema F, Carella AM, Santini G. A to O bone marrow transplantation in severe aplastic anaemia: dynamics of blood group conversion and demonstration of early dyserythropoiesis in the engrafted marrow. Br J Haematol 1977 36 : 511 8.
8. Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM, Laffan M. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997 19 : 491 5.
9. Drobyski WR, Potluri J, Sauer D, Gottschall JL. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996 17 : 1093 9.
10. Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett AJ, Childs RW. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001 98 : 1687 94.
11. Griffith LM, McCoy JP Jr., Bolan CD, Stroncek DF, Pickett AC, Linton GF, Lunrdqvist A, Srinivasan R, Leitman SF, Childs RW. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005 128 : 668 75.
12. Witherspoon RP, Schanfield MS, Storb R, Thomas ED, Giblett ER. Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia. Transplantation 1978 26 : 407 8.
13. van Tol MJ, Gerritsen EJ, de Lange GG, van Leeuwen AM, Jol-van der Zijde CM, Oudeman-Gruber NJ, de Vries E, Radl J, Vossen JM. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 1996 87 : 818 26.
14. Hammarstrom L, Smith CI. Frequent occurrence of monoclonal gammopathies with an imbalanced light-chain ratio following bone marrow transplantation. Transplantation 1987 43 : 447 9.
15. Klumpp TR, Caligiuri MA, Rabinowe SN, Soiffer RJ, Murray C, Ritz J. Autoimmune pancytopenia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990 6 : 445 7.
16. Hammarstrom L, de Lange GG, Smith CI. IgA2 allotypes determined by restriction fragment length polymorphism in IgA deficiency. Re-expression of the silent A2m(2) allotype in the children of IgA-deficient patients. J Immunogenet 1987 14 : 197 201.
17. Hammarstrom L, Smith CI. Development of IgG2 deficiency in a bone-marrow-transplanted patient. Implication for generation of the anticarbohydrate antibody repertoire in subclass-deficient individuals. Transplantation 1987 43 : 917 9.
18. Kent EF Jr., Crawford J, Cohen HJ, Buckley RH. Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency. J Clin Immunol 1990 10 : 106 14.
19. Myint H, Copplestone JA, Orchard J, Craig V, Curtis D, Prentice AG, Hamon MD, Oscier DG, Hamblin TJ. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995 91 : 341 4.
20. Worel N, Greinix HT, Supper V, Leitner G, Mitterbauer M, Rabitsch W, Fischer G, Rosenmayr A, Hocker P, Kalhs P. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning. Transfusion 2007 47 : 1494 502.
21. Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, Spitzer T, Weisdorf D. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001 7 : 473 85.
22. Heemskerk MH, Hagedoorn RS, van der Hoorn MA, van der Veken LT, Hoogeboom M, Kester MG, Willemze R, Frederik Falkenburg JH. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 2007 109 : 235 43.
23. Klaesson S. Clinical use of rHuEPO in bone marrow transplantation. Med Oncol 1999 16 : 2 7.
24. Stussi G, Halter J, Bucheli E, Valli PV, Seebach L, Gmür J, Gratwohl A, Schanz U, Passweg JR, Seebach JD. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica 2009 94 : 239 48.